Workflow
亮晴控股(08603) - 2020 Q3 - 季度财报
FAMEGLOWFAMEGLOW(HK:08603)2020-02-14 08:33

Financial Performance - For the nine months ended December 31, 2019, the group's revenue was approximately HKD 74.1 million, compared to HKD 70.3 million for the same period in 2018, representing an increase of 3.8%[10] - The group incurred a net loss of approximately HKD 13.4 million for the nine months ended December 31, 2019, compared to a net loss of HKD 6.3 million for the same period in 2018, indicating a deterioration in performance[10] - The basic loss per share for the nine months ended December 31, 2019, was HKD 1.68, compared to HKD 0.96 for the same period in 2018, reflecting a significant increase in losses per share[13] - The total comprehensive loss for the period was HKD 13.4 million, compared to HKD 6.3 million for the same period in 2018, indicating a worsening financial position[13] - The company's revenue for the nine months ended December 31, 2019, was approximately HKD 74.1 million, an increase of about HKD 3.8 million or 5.4% compared to the same period in 2018[45] - The loss for the nine months ended December 31, 2019, was approximately HKD 13.4 million, compared to a loss of HKD 6.3 million in the same period in 2018[45] Cost and Expenses - The cost of inventories and consumables for the nine months ended December 31, 2019, was HKD 8.2 million, up from HKD 6.9 million in the same period of 2018, indicating rising costs[13] - Employee costs increased to HKD 36.5 million for the nine months ended December 31, 2019, compared to HKD 24.4 million in the same period of 2018, showing a rise of 49.5%[13] - The group reported a significant increase in rental and related expenses, which amounted to HKD 2.9 million for the nine months ended December 31, 2019, compared to HKD 8.0 million in the same period of 2018[13] - Other expenses for the nine months ended December 31, 2019, were approximately HKD 21.7 million, up from HKD 14.8 million in the same period in 2018, driven by increased promotional activities to enhance brand awareness and capture market share[56] - Depreciation expenses for property, plant, and equipment increased to approximately HKD 6.0 million for the nine months ended December 31, 2019, compared to HKD 4.2 million for the same period in 2018, mainly due to the acquisition of property, plant, and equipment[54] - The group recorded a right-of-use asset depreciation of approximately HKD 10.9 million for the nine months ended December 31, 2019, compared to zero for the same period in 2018, due to the adoption of HKFRS 16[55] Revenue Sources - Revenue from skincare product sales reached HKD 70,664 thousand for the nine months ended December 31, 2019, compared to HKD 66,752 thousand in the same period of 2018, representing an increase of approximately 2.8%[32] - Total revenue for the nine months ended December 31, 2019, was HKD 74,110 thousand, up from HKD 70,288 thousand in the previous year, indicating a growth of about 5.3%[32] - Prepaid treatment income for the nine months ended December 31, 2019, was HKD 784 thousand, down from HKD 1,102 thousand in the same period of 2018, reflecting a decrease of approximately 29%[32] Dividends and Equity - The board does not recommend the payment of any dividends for the nine months ended December 31, 2019, reflecting the company's focus on financial recovery[11] - The group's total equity as of December 31, 2019, was HKD 57.3 million, down from HKD 70.7 million as of April 1, 2019, indicating a decline in shareholder equity[15] - The company did not recommend any dividend for the nine months ended December 31, 2019, consistent with the same period in 2018[39] - The board did not recommend any dividend distribution for the nine months ended December 31, 2019, consistent with the same period in 2018[58] Corporate Governance and Compliance - The company has maintained compliance with the corporate governance code as per GEM Listing Rules, except for a temporary vacancy in the company secretary position[59] - The audit committee reviewed the unaudited consolidated results for the nine months ended December 31, 2019, and confirmed compliance with applicable accounting standards and GEM Listing Rules[62] Business Operations and Strategy - The company opened two new centers in Central and Causeway Bay in May and June 2019, respectively, to expand its operational scale[46] - The company plans to implement promotional activities to maintain market share in response to economic and business environment challenges[48] - The company believes that the medical beauty service industry outlook remains optimistic despite recent challenges, and it aims to leverage its strong customer base and reputation for steady business growth[48] Financial Reporting Standards - The financial statements are prepared in accordance with the Hong Kong Financial Reporting Standards, specifically HKFRS 16 on leases, which was adopted during the reporting period[25] - The group has recognized lease liabilities based on the present value of lease payments, which include fixed payments and variable lease payments based on indices or rates[26] - The initial measurement of right-of-use assets is equivalent to the amount of lease liabilities recognized, adjusted for any lease payments made before the commencement date[29] - The financial statements are presented in Hong Kong dollars (HKD), which is also the functional currency of the company and its main subsidiaries[1] Shareholding Structure - The major shareholders, Mr. Ye and Ms. Fu, each hold a 75% interest in the company through a controlled corporation, Equal Joy, which has 600,000,000 shares[66] - Equal Joy holds 600,000,000 shares, representing 75% of the company's equity[69] Stock Options and Securities - The stock option plan was adopted for ten years to attract and reward qualified individuals contributing to the group[71] - No stock options, warrants, or convertible securities have been granted or exercised since the adoption of the stock option plan[71] - There are no arrangements allowing directors to acquire shares or debt securities for personal benefit[72] - No directors or their associates are engaged in any business that competes directly or indirectly with the group[74]